Arturo Carratala Calvo-rekin lankidetzan egindako argitalpenak (9)

2020

  1. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

    American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4

  2. Similar clinical course and significance of circulating innate and adaptive immune cell counts in stemi and COVID-19

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-19

  3. Undetectable high-sensitivity troponin in combination with clinical assessment for risk stratification of patients with chest pain and normal troponin at hospital arrival

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 6, pp. 567-575

2018

  1. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality

    Circulation, Vol. 137, Núm. 13, pp. 1320-1330

2017

  1. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design

    Revista Espanola de Cardiologia, Vol. 70, Núm. 12, pp. 1067-1073

2015

  1. Procalcitonin and long-term prognosis after an admission for acute heart failure

    European Journal of Internal Medicine, Vol. 26, Núm. 1, pp. 42-48

2012

  1. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure

    International Journal of Cardiology, Vol. 159, Núm. 1, pp. 21-28

  2. Metabolomic profile of human myocardial ischemia by nuclear magnetic resonance spectroscopy of peripheral blood serum: A translational study based on transient coronary occlusion models

    Journal of the American College of Cardiology, Vol. 59, Núm. 18, pp. 1629-1641

2010

  1. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure

    European Heart Journal, Vol. 31, Núm. 14, pp. 1752-1763